Idaho Copper Corp 8-K

What Happened

• Idaho Copper Corporation (COPR) announced on July 1, 2026 that it entered into an underwriting agreement with ThinkEquity, LLC to sell 3,712,000 shares of common stock and accompanying warrants to purchase 3,712,000 shares at a public offering price of $4.85 per share and warrant, for total gross proceeds of about $18 million. The offering is expected to close on July 6, 2026.
• The company granted the underwriters a 45-day option to purchase up to an additional 566,800 shares and/or warrants to cover over‑allotments. The registration statement on Form S-1 (File No. 333-290746) was declared effective by the SEC on July 1, 2026.

Key Details

• Underwriter: ThinkEquity, LLC (representative).
• Offered securities: 3,712,000 common shares + 3,712,000 warrants; warrant exercise price $5.75 per share.
• Offering price & proceeds: $4.85 per share and accompanying warrant; gross proceeds ~ $18M, estimated net proceeds ~ $16M after fees and expenses.
• Use of proceeds: complete an updated Preliminary Economic Assessment (PEA), first-phase preliminary work on a Prefeasibility Study (PFS), and general corporate purposes/working capital.
• Listing: Approved to list common stock and warrants on NYSE American; common shares expected to begin trading July 2, 2026 under symbol COPR, warrants under COPR WS.

Why It Matters

• This capital raise provides Idaho Copper with funding specifically earmarked for advancing project studies (PEA and early PFS work) and for general corporate needs—key steps in advancing a mining development pipeline.
• The offering is dilutive: new shares plus up to an equal number of warrants (and potential additional shares if the over‑allotment option is exercised) will increase share count; warrants convert only if holders exercise at $5.75 per share.
• The NYSE American listing may improve liquidity and visibility for retail and institutional investors. Investors should weigh the expected use of proceeds against dilution and monitor closing, over‑allotment exercise, and subsequent filings for final results.